These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21021618)

  • 41. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
    Ohyama T; Hori T; Moriike M; Asano T; Hayashi H; Iwade K; Hosoda S
    Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose heparin in gynecologic surgery: effect on blood coagulation tests.
    Levesque G; Samama M; Kher A; Barbier P; Horellou MH; Conard J
    Haemostasis; 1981; 10(2):97-103. PubMed ID: 7461507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EFFECT OF ADENOSINE NUCLEOTIDES ON PLATELET AGGREGATION AND CLOTTING TIME.
    MUSTARD JF; HEGARDT B; ROWSELL HC; MACMILLAN RL
    J Lab Clin Med; 1964 Oct; 64():548-59. PubMed ID: 14233144
    [No Abstract]   [Full Text] [Related]  

  • 44. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 45. Blood coagulation and thrombosis in patients with ovarian malignancy.
    von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
    Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RELEASE OF A PLATELET-AGGREGATING SUBSTANCE (ADENOSINE DIPHOSPHATE) FROM RABBIT BLOOD PLATELETS INDUCED BY SALINE "EXTRACT" OF TENDONS.
    HOVIG T
    Thromb Diath Haemorrh; 1963 Jul; 143():264-78. PubMed ID: 14081250
    [No Abstract]   [Full Text] [Related]  

  • 47. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viscoelastic blood coagulation measurement with Sonoclot predicts postoperative bleeding in cardiac surgery after heparin reversal.
    Bischof DB; Ganter MT; Shore-Lesserson L; Hartnack S; Klaghofer R; Graves K; Genoni M; Hofer CK
    J Cardiothorac Vasc Anesth; 2015; 29(3):715-22. PubMed ID: 25864405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
    Jackson CV; Crowe VG; Frank JD; Wilson HC; Coffman WJ; Utterback BG; Jakubowski JA; Smith GF
    J Pharmacol Exp Ther; 1992 May; 261(2):546-52. PubMed ID: 1578372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship of disorders of the blood-clotting mechanism to toxemia of pregnancy and the value of heparin in therapy.
    BUTLER BC; TAYLOR HC; GRAFF S
    Am J Obstet Gynecol; 1950 Sep; 60(3):564-74. PubMed ID: 14771146
    [No Abstract]   [Full Text] [Related]  

  • 53. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparin Reversal After Cardiopulmonary Bypass: Are Point-of-Care Coagulation Tests Interchangeable?
    Willems A; Savan V; Faraoni D; De Ville A; Rozen L; Demulder A; Van der Linden P
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1184-9. PubMed ID: 27461795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relation between heparin blood levels and blood coagulation times.
    MONKHOUSE FC; MACMILLAN RL; BROWN KW
    J Lab Clin Med; 1953 Jul; 42(1):92-7. PubMed ID: 13061833
    [No Abstract]   [Full Text] [Related]  

  • 57. The control of anticoagulant therapy by a sensitized clotting time.
    de TAKATS G
    J Lab Clin Med; 1950 Nov; 36(5):818. PubMed ID: 14784683
    [No Abstract]   [Full Text] [Related]  

  • 58. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitigation of coagulation by removing clotting factors part 2: heparin-free extracorporeal circulation in a porcine model.
    Sukavaneshvar S; Parker JT; Beutler DS; Burns G; Solen KA; Mohammad SF
    ASAIO J; 2007; 53(4):421-7. PubMed ID: 17667225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [THROMBOSIS, ARTERIOSCLEROSIS AND HYPERCOAGULABILITY].
    ULUTIN ON; AKMAN N; OZCAN E
    Turk Tip Cemiy Mecm; 1963 Aug; 29():428-32. PubMed ID: 14088134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.